These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25728938)

  • 1. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
    Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
    Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
    Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
    PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
    Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
    Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.
    Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S
    Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
    Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
    Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
    D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
    Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.
    Zielinska HA; Holly JMP; Bahl A; Perks CM
    Cancer Lett; 2018 Apr; 419():187-202. PubMed ID: 29331414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.
    Karamanou K; Franchi M; Vynios D; Brézillon S
    Semin Cancer Biol; 2020 May; 62():125-133. PubMed ID: 31401293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα+ breast cancer MCF-7 cells.
    Rieber M; Strasberg-Rieber M
    Biochem Pharmacol; 2014 Mar; 88(2):169-77. PubMed ID: 24486524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status.
    Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.
    Huderson BP; Duplessis TT; Williams CC; Seger HC; Marsden CG; Pouey KJ; Hill SM; Rowan BG
    Endocrinology; 2012 Sep; 153(9):4144-59. PubMed ID: 22733972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
    Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
    Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
    M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix.
    Epstein Shochet G; Drucker L; Pomeranz M; Fishman A; Pasmanik-Chor M; Tartakover-Matalon S; Lishner M
    Mol Carcinog; 2017 Jan; 56(1):62-74. PubMed ID: 26859229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
    Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.
    Yang KM; Jung Y; Lee JM; Kim W; Cho JK; Jeong J; Kim SJ
    Cancer Res; 2013 Nov; 73(22):6679-89. PubMed ID: 24062311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules.
    Afratis NA; Bouris P; Skandalis SS; Multhaupt HA; Couchman JR; Theocharis AD; Karamanos NK
    Sci Rep; 2017 Jan; 7():40138. PubMed ID: 28079144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.